Global /United States /Healthcare /Medical Devices /NTRB

Nutriband Inc.

NTRB

• NASDAQ: NTRB • Delayed

3.79USD 0.8%

As of 13 June 2026, Nutriband Inc. has a market cap of $46.07M USD, ranking #31173 globally and #4513 in the United States. It ranks #2817 in the Healthcare sector, and #583 in the Medical Devices industry.

Global Rank

31173

Country Rank

4513

Sector Rank

2817

Industry Rank

583

Key Stats

Market Cap

$46.07MUSD

Enterprise Value

$41.02MUSD

Revenue (TTM)

$2.28MUSD

EBITDA (TTM)

-$9.03MUSD

Net Income (TTM)

-$34.59MUSD

PS Ratio

20.2

PB Ratio

6.1

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Devices

CEO

Gareth Sheridan open_in_new

Employees

Founded

2016

Website

nutriband.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.8%	-8.9%	-1.3%	-19%	-51%	-16%	-35%	14%	-75%

News

NTRB Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	NTRB Nutriband Inc ISIN: US67092M2089 Shares Out.: Shares Outstanding: 12.156M¹ Shares Float: 5.25M² TV: TradingView: NASDAQ: NTRB SA: Stock Analysis: NASDAQ: NTRB YF: Yahoo Finance: NTRB GF: Google Finance: NASDAQ: NTRB NQ: NASDAQ: NTRB BA: Barron's: NTRB MS: Morningstar: XNAS: NTRB	3.79 USD	TV: TradingView: NASDAQ: NTRB SA: Stock Analysis: NASDAQ: NTRB YF: Yahoo Finance: NTRB GF: Google Finance: NASDAQ: NTRB NQ: NASDAQ: NTRB BA: Barron's: NTRB MS: Morningstar: XNAS: NTRB

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company’s lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Similar Companies

Industry: Medical Devices (United States)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 376K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 349K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 345K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 275K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 262K%	38.3	United States
Boston Scientific Corp. NYSE: BSX	$84.93B 184K%	24.5	United States

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Medtronic plc NYSE: MDT	$101.9B 221K%	22.2	Ireland
EssilorLuxottica Société anonyme EPA: EL	$97.46B 84.32B EUR 211K%	36.7	France
HOYA Corp. TSE: 7741	$61.41B 9.83T JPY 133K%	40.0	Japan
Siemens Healthineers AG XETRA: SHL	$45.47B 39.34B EUR 99K%	18.7	Germany
Alcon Inc. SIX: ALC	$36.38B 28.99B CHF 79K%	37.9	Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 65K%	26.0	China

chevron_leftBack